ALX Oncology Holdings Inc.

Last updated September 27, 2026

Organization details

Legal name
ALX Oncology Holdings Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
South SAN Francisco
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
December
Ticker symbol
ALXO
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001810182
EIN
85-0642577

Board of directors

Chief executives

Jaume Pons · President & CEO
Dates unknown
Jason Lettmann · Chief Executive Officer
Dates unknown

Director election results

Annual meeting of June 10, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

5 of this board's directors also sit on 11 other boards. 11 are in the same sector.

Network of ALX Oncology Holdings Inc.'s board connections LB Pharmaceuticals Inc LB Pharmaceuticals Inc Aligos Therapeutics Inc. Aligos Therapeutics In... BioAge Labs Inc. BioAge Labs Inc. Enliven Therapeutics Inc. Enliven Therapeutics I... Harmony Biosciences Holdings Inc. Harmony Biosciences Ho... Instil Bio Inc. Instil Bio Inc. MaxCyte Inc. MaxCyte Inc. Olema Pharmaceuticals Inc. Olema Pharmaceuticals... TScan Therapeutics Inc. TScan Therapeutics Inc... Xencor Inc. Xencor Inc. Xilio Therapeutics Inc. Xilio Therapeutics Inc... Barbara Klencke Barbara Klencke Daniel J. Curran Daniel J. Curran J. Scott Garland J. Scott Garland Jack Nielsen Jack Nielsen Rekha Hemrajani Rekha Hemrajani ALX Oncology Holdings Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$4,999,999
1 purchase by 1 insider
Sold, last 12 months
$42,588
7 sales by 2 insiders
Date Insider Transaction Shares Price Value
Aug 17, 2026 Wong Shelly Officer (SVP, FINANCE AND CAO) Open-market sale −573 $1.93 $1,106
Aug 17, 2026 Jason Lettmann Director, Officer (CHIEF EXECUTIVE OFFICER) Open-market sale −2,230 $1.93 $4,304
Jul 1, 2026 Wong Shelly Officer (SVP, FINANCE AND CAO) Open-market sale −1,404 $2.04 $2,864
Mar 19, 2026 Jason Lettmann Director, Officer (CHIEF EXECUTIVE OFFICER) Open-market sale −12,311 $2.17 $26,715
Mar 19, 2026 Pinto Shelly Officer (SVP, FINANCE AND CAO) Open-market sale −903 $2.17 $1,960
Feb 18, 2026 Pinto Shelly Officer (SVP, FINANCE AND CAO) Open-market sale −565 $2.27 $1,283
Feb 17, 2026 Jason Lettmann Director, Officer (CHIEF EXECUTIVE OFFICER) Shares withheld for tax −2,201 $2.27 $4,996
Feb 2, 2026 Corey S. Goodman Director, 10% owner Open-market purchase +3,184,713 $1.57 $4,999,999
Jan 6, 2026 Pinto Shelly Officer (SVP, FINANCE AND CAO) Open-market sale −3,925 $1.11 $4,357
Sep 17, 2025 Jason Lettmann Director, Officer (CHIEF EXECUTIVE OFFICER) Open-market purchase +71,163 $1.08 $76,856
Sep 16, 2025 Jason Lettmann Director, Officer (CHIEF EXECUTIVE OFFICER) Open-market purchase +21,070 $1.07 $22,545
Aug 18, 2025 Shantharam Harish Officer (Chief Financial Officer) Open-market purchase +75,000 $0.78 $58,500
Aug 15, 2025 Pinto Shelly Officer (SVP, FINANCE AND CAO) Open-market sale −611 $0.64 $391
Aug 15, 2025 Jason Lettmann Director, Officer (CHIEF EXECUTIVE OFFICER) Open-market sale −2,382 $0.64 $1,524
Jul 7, 2025 Pinto Shelly Officer (SVP, FINANCE AND CAO) Open-market sale −2,011 $0.45 $905

Organizations in the same sector, closest in location and size first.

Questions about ALX Oncology Holdings Inc.

Who is the CEO of ALX Oncology Holdings Inc.?

Jaume Pons is ALX Oncology Holdings Inc.'s President & CEO.

How many directors are on ALX Oncology Holdings Inc.'s board?

ALX Oncology Holdings Inc.'s board has 12 directors: Alan B. Sandler, Barbara Klencke, Chris H. Takimoto, Corey S. Goodman, Daniel J. Curran, Itziar Canamasas, J. Scott Garland, Jack Nielsen, Jason Lettmann, Jaume Pons and 2 others.

Are ALX Oncology Holdings Inc. insiders buying or selling shares?

Over the last 12 months, ALX Oncology Holdings Inc. insiders bought $5.0 million of shares in 1 purchase and sold $42,588 of shares in 7 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="alx-oncology-holdings-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.